Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Dopamine -- Agonists"" wg kryterium: Temat


Tytuł :
Dopamine receptor agonists ameliorate bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation.
Autorzy :
Mou Y; Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Key Site of National Clinical Research Center for Respiratory Disease, Wuhan Clinical Medical Research Center for Chronic Airway Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave, Wuhan 430030, China.
Liu J; Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Key Site of National Clinical Research Center for Respiratory Disease, Wuhan Clinical Medical Research Center for Chronic Airway Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave, Wuhan 430030, China.
Pan T; Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Key Site of National Clinical Research Center for Respiratory Disease, Wuhan Clinical Medical Research Center for Chronic Airway Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave, Wuhan 430030, China.
Wang Q; Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Key Site of National Clinical Research Center for Respiratory Disease, Wuhan Clinical Medical Research Center for Chronic Airway Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave, Wuhan 430030, China.
Miao K; Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Key Site of National Clinical Research Center for Respiratory Disease, Wuhan Clinical Medical Research Center for Chronic Airway Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave, Wuhan 430030, China.
Xu Y; Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Key Site of National Clinical Research Center for Respiratory Disease, Wuhan Clinical Medical Research Center for Chronic Airway Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave, Wuhan 430030, China.
Xiong W; Department of Respiratory Medicine, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, 639 Zhizaoju Lu, Shanghai 200011, China.
Yu J; Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave, Wuhan 430030, China. Electronic address: .
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Jul; Vol. 139, pp. 111500. Date of Electronic Publication: 2021 Apr 23.
Typ publikacji :
Journal Article
MeSH Terms :
Antibiotics, Antineoplastic*
Bleomycin*
Dopamine Agonists/*therapeutic use
Fibroblasts/*drug effects
Pulmonary Fibrosis/*chemically induced
Pulmonary Fibrosis/*drug therapy
Animals ; Benzimidazoles/pharmacology ; Cell Differentiation/drug effects ; Cell Proliferation/drug effects ; Dopamine Agonists/pharmacology ; Fenoldopam/pharmacology ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Phosphorylation/drug effects ; Receptors, Dopamine D1/drug effects ; Receptors, Dopamine D2/drug effects ; Smad2 Protein/metabolism ; Transforming Growth Factor beta1/metabolism ; Up-Regulation/drug effects
Czasopismo naukowe
Tytuł :
Computational study on new natural compound agonists of dopamine receptor.
Autorzy :
Li H; Department of Neurology, The First Hospital of Jilin University, Changchun, China.
Yang W; Clinical College, Jilin University, Changchun, China.
Xi J; Clinical College, Jilin University, Changchun, China.
Wang Z; Clinical College, Jilin University, Changchun, China.
Lu H; Clinical College, Jilin University, Changchun, China.
Du Z; Clinical College, Jilin University, Changchun, China.
Li W; Department of Orthopaedic Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Wu B; Department of Orthopaedic Surgery, The First Hospital of Jilin University, Changchun, China.
Jiang S; Chinese Academy of Sciences, Research Group of Evolution and Population Genomics, Institute of Zoology, Beijing, China.
Peng Y; College of Computer Science and Technology, Jilin University, Changchun, China.
Liu J; Department of Biomedical Informatics, Harvard Medical School, Cambridge, MA 02115, USA.
Liu L; Department of Biomedical Informatics, Harvard Medical School, Cambridge, MA 02115, USA.
Zhang X; Department of Neurosurgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Feng J; Department of Neurology, The First Hospital of Jilin University, Changchun, China.
Pokaż więcej
Źródło :
Aging [Aging (Albany NY)] 2021 Jun 25; Vol. 13 (12), pp. 16620-16636. Date of Electronic Publication: 2021 Jun 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Molecular Docking Simulation*
Biological Products/*chemistry
Biological Products/*pharmacology
Dopamine Agonists/*chemistry
Dopamine Agonists/*pharmacology
Receptors, Dopamine/*chemistry
Biological Products/analysis ; Biological Products/toxicity ; Bromocriptine/chemistry ; Bromocriptine/pharmacology ; Cell Line, Tumor ; Cell Survival/drug effects ; Dopamine Agonists/analysis ; Dopamine Agonists/toxicity ; Drug Evaluation, Preclinical ; Humans ; Hydrogen Bonding ; Ligands ; Molecular Dynamics Simulation ; Prolactin/metabolism
Czasopismo naukowe
Tytuł :
The High Affinity Dopamine D 2 Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders.
Autorzy :
Subburaju S; Division of Basic Neuroscience, Medicinal Chemistry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, United States.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115, United States.
Sromek AW; Division of Basic Neuroscience, Medicinal Chemistry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, United States.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115, United States.
Seeman P; Departments of Pharmacology and Psychiatry, University of Toronto, 260 Heath St. West, unit 605, Toronto, Ontario M5P 3L6, Canada.
Neumeyer JL; Division of Basic Neuroscience, Medicinal Chemistry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, United States.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115, United States.
Pokaż więcej
Źródło :
ACS chemical neuroscience [ACS Chem Neurosci] 2021 Apr 21; Vol. 12 (8), pp. 1428-1437. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Dopamine Agonists*/pharmacology
Nervous System Diseases*
Animals ; Apomorphine/analogs & derivatives ; Corpus Striatum/metabolism ; Dopamine ; Raclopride ; Rats ; Receptors, Dopamine D2/metabolism ; Receptors, Dopamine D3
Czasopismo naukowe
Tytuł :
Dopamine D 2 Receptor Agonist Binding Kinetics-Role of a Conserved Serine Residue.
Autorzy :
Ågren R; Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden.
Stepniewski TM; Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM)-Pompeu Fabra University (UPF), 08003 Barcelona, Spain.; InterAx Biotech AG, 5234 Villigen, Switzerland.; Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, 02-089 Warsaw, Poland.
Zeberg H; Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden.
Selent J; Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM)-Pompeu Fabra University (UPF), 08003 Barcelona, Spain.
Sahlholm K; Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden.; Department of Integrative Medical Biology, Wallenberg Centre for Molecular Medicine, Umeå University, 901 87 Umeå, Sweden.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 15; Vol. 22 (8). Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article
MeSH Terms :
Dopamine Agonists/*metabolism
Receptors, Dopamine D2/*chemistry
Receptors, Dopamine D2/*metabolism
Serine/*metabolism
8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacology ; Animals ; Conserved Sequence ; Dopamine/metabolism ; Dopamine Agonists/chemistry ; Humans ; Kinetics ; Mutant Proteins/metabolism ; Mutation/genetics ; Phenethylamines/pharmacology ; Protein Binding ; Structure-Activity Relationship ; Tyramine/metabolism ; Xenopus laevis
Czasopismo naukowe
Tytuł :
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
Autorzy :
Tang H; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
Mourad SM; Radboud University Medical Centre, Nijmegen, Netherlands.
Wang A; Department of Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
Zhai SD; Department of Pharmacy, Therapeutic Drug Monitoring and Clinical Toxicology Center of Peking University, Peking University Third Hospital, Beijing, China.
Hart RJ; School of Women's and Infants' Health, The University of Western Australia, King Edward Memorial Hospital and Fertility Specialists of Western Australia, Subiaco, Perth, Australia.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 Apr 14; Vol. 4. Cochrane AN: CD008605. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Fertilization in Vitro*
Dopamine Agonists/*therapeutic use
Ovarian Hyperstimulation Syndrome/*prevention & control
Abortion, Spontaneous/prevention & control ; Administration, Oral ; Aminoquinolines/therapeutic use ; Bromocriptine/therapeutic use ; Cabergoline/therapeutic use ; Dopamine Agonists/administration & dosage ; Ergolines/therapeutic use ; Female ; Humans ; Live Birth/epidemiology ; Ovarian Hyperstimulation Syndrome/epidemiology ; Placebos/therapeutic use ; Pregnancy ; Pregnancy Rate ; Randomized Controlled Trials as Topic ; Sperm Injections, Intracytoplasmic
Czasopismo naukowe
Tytuł :
Pramipexole-induced oedema: the importance of renal dopamine.
Autorzy :
Tan SJ; Department of General Medicine, St John of God Midland Hospital, Perth, Western Australia, Australia.
Prentice D; Department of General Medicine, St John of God Midland Hospital, Perth, Western Australia, Australia.
Pokaż więcej
Źródło :
Internal medicine journal [Intern Med J] 2021 Apr; Vol. 51 (4), pp. 618-619.
Typ publikacji :
Letter
MeSH Terms :
Dopamine*
Dopamine Agonists*/adverse effects
Benzothiazoles/adverse effects ; Edema ; Humans ; Pramipexole
Opinia redakcyjna
Tytuł :
Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the H 2 R and D 3 R.
Autorzy :
Biselli S; Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053, Regensburg, Germany; Agrolab Labor GmbH, 84079, Bruckberg, Germany.
Bresinsky M; Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053, Regensburg, Germany.
Tropmann K; Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053, Regensburg, Germany.
Forster L; Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053, Regensburg, Germany.
Honisch C; Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053, Regensburg, Germany; Institute of Biomolecular Chemistry - National Research Council (ICB-CNR), Padua Unit Via F. Marzolo, 1, 35131, Padova, Italy.
Buschauer A; Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053, Regensburg, Germany.
Bernhardt G; Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053, Regensburg, Germany.
Pockes S; Institute of Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053, Regensburg, Germany; Department of Neurology, University of Minnesota, Minneapolis, MN, 55455, USA; Department of Medicinal Chemistry, Institute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, 55414, USA. Electronic address: .
Pokaż więcej
Źródło :
European journal of medicinal chemistry [Eur J Med Chem] 2021 Mar 15; Vol. 214, pp. 113190. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article
MeSH Terms :
Dopamine Agonists/*pharmacology
Guanidines/*pharmacology
Receptors, Dopamine D3/*agonists
Receptors, Histamine H2/*metabolism
Animals ; Cells, Cultured ; Dopamine Agonists/chemical synthesis ; Dopamine Agonists/chemistry ; Dose-Response Relationship, Drug ; Guanidines/chemical synthesis ; Guanidines/chemistry ; Guinea Pigs ; HEK293 Cells ; Humans ; Ligands ; Molecular Structure ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
Discovery of a true bivalent dopamine D 2 receptor agonist.
Autorzy :
Qian M; Department of Medicinal Chemistry, School of Pharmacy, Changzhou University, Changzhou, 213164, Jiangsu, China; Laboratory for Medicinal Chemistry, Ghent University, Ottergemsesteenweg 460, B-9000, Ghent, Belgium.
Ricarte A; Laboratory of Molecular Neuropharmacology and Bioinformatics, Unitat de Bioestadística, Institut de Neurociències, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain; Unitat de Neurociència Traslacional, Parc Taulí Hospital Universitari, Institut d'Investigaciói InnovacióParc Taulí (I3PT), Institut de Neurociències, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Wouters E; Laboratory of Toxicology, Ghent University, Ottergemsesteenweg 460, B-9000, Ghent, Belgium.
Dalton JAR; Laboratory of Molecular Neuropharmacology and Bioinformatics, Unitat de Bioestadística, Institut de Neurociències, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain; Unitat de Neurociència Traslacional, Parc Taulí Hospital Universitari, Institut d'Investigaciói InnovacióParc Taulí (I3PT), Institut de Neurociències, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Risseeuw MDP; Laboratory for Medicinal Chemistry, Ghent University, Ottergemsesteenweg 460, B-9000, Ghent, Belgium.
Giraldo J; Laboratory of Molecular Neuropharmacology and Bioinformatics, Unitat de Bioestadística, Institut de Neurociències, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain; Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain; Unitat de Neurociència Traslacional, Parc Taulí Hospital Universitari, Institut d'Investigaciói InnovacióParc Taulí (I3PT), Institut de Neurociències, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain.
Van Calenbergh S; Laboratory for Medicinal Chemistry, Ghent University, Ottergemsesteenweg 460, B-9000, Ghent, Belgium. Electronic address: .
Pokaż więcej
Źródło :
European journal of medicinal chemistry [Eur J Med Chem] 2021 Feb 15; Vol. 212, pp. 113151. Date of Electronic Publication: 2021 Jan 04.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Discovery*
Dopamine Agonists/*pharmacology
Receptors, Dopamine D2/*agonists
Cells, Cultured ; Dopamine Agonists/chemical synthesis ; Dopamine Agonists/chemistry ; Dose-Response Relationship, Drug ; HEK293 Cells ; Humans ; Models, Molecular ; Molecular Structure ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
Development of pyrimidone D1 dopamine receptor positive allosteric modulators.
Autorzy :
Luderman KD; Molecular Neuropharmacology Section, NINDS, National Institutes of Health, Bethesda, MD, United States.
Jain P; Specialized Chemistry Center, University of Kansas, Lawrence, KS, United States.
Benjamin Free R; Molecular Neuropharmacology Section, NINDS, National Institutes of Health, Bethesda, MD, United States.
Conroy JL; Molecular Neuropharmacology Section, NINDS, National Institutes of Health, Bethesda, MD, United States.
Aubé J; Specialized Chemistry Center, University of Kansas, Lawrence, KS, United States; Center for Integrative Chemical Biology and Drug Discovery, UNC Eshelman School of Pharmacy, Chapel Hill, NC 27599-7363, United States.
Sibley DR; Molecular Neuropharmacology Section, NINDS, National Institutes of Health, Bethesda, MD, United States. Electronic address: .
Frankowski KJ; Specialized Chemistry Center, University of Kansas, Lawrence, KS, United States; Center for Integrative Chemical Biology and Drug Discovery, UNC Eshelman School of Pharmacy, Chapel Hill, NC 27599-7363, United States. Electronic address: .
Pokaż więcej
Źródło :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2021 Jan 01; Vol. 31, pp. 127696. Date of Electronic Publication: 2020 Nov 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Development*
Dopamine Agonists/*pharmacology
Receptors, Dopamine D1/*agonists
Allosteric Regulation/drug effects ; Dopamine Agonists/chemical synthesis ; Dopamine Agonists/chemistry ; Dose-Response Relationship, Drug ; Humans ; Molecular Structure ; Receptors, Dopamine D1/metabolism ; Signal Transduction/drug effects ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
Homobivalent Dopamine D 2 Receptor Ligands Modulate the Dynamic Equilibrium of D 2 Monomers and Homo- and Heterodimers.
Autorzy :
Ullmann T; Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany.
Gienger M; Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany.
Budzinski J; Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany.
Hellmann J; Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany.
Hübner H; Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany.
Gmeiner P; Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany.
Weikert D; Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nikolaus-Fiebiger-Str. 10, 91058 Erlangen, Germany.
Pokaż więcej
Źródło :
ACS chemical biology [ACS Chem Biol] 2021 Feb 19; Vol. 16 (2), pp. 371-379. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Dopamine Agonists/*pharmacology
Dopamine D2 Receptor Antagonists/*pharmacology
Polyethylene Glycols/*pharmacology
Protein Multimerization/*drug effects
Receptors, Dopamine D2/*metabolism
Dopamine Agonists/chemical synthesis ; Dopamine D2 Receptor Antagonists/chemical synthesis ; HEK293 Cells ; Humans ; Indans/chemical synthesis ; Indans/pharmacology ; Ligands ; Piperazines/chemical synthesis ; Piperazines/pharmacology ; Polyethylene Glycols/chemical synthesis
Czasopismo naukowe
Tytuł :
Lack of effect of dopamine receptor blockade on SKF83959-altered operant behavior in male rats.
Autorzy :
Liu PP; Department of Psychology, National Cheng-Chi University, Taipei, Taiwan.
Chao CC; Institute of Neuroscience; Research Center for Mind, Brain and Learning, National Cheng-Chi University, Taipei, Taiwan.
Liao RM; Department of Psychology; Institute of Neuroscience; Research Center for Mind, Brain and Learning, National Cheng-Chi University, Taipei, Taiwan.
Pokaż więcej
Źródło :
The Chinese journal of physiology [Chin J Physiol] 2021 Jan-Feb; Vol. 64 (1), pp. 1-15.
Typ publikacji :
Journal Article
MeSH Terms :
Dopamine Agonists*/pharmacology
Receptors, Dopamine D1*
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/analogs & derivatives ; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology ; Animals ; Behavior, Animal ; Male ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł :
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson's disease.
Autorzy :
Cerri S; Laboratory of Cellular and Molecular Neurobiology, IRCCS Mondino Foundation , Pavia, Italy.
Blandini F; Laboratory of Cellular and Molecular Neurobiology, IRCCS Mondino Foundation , Pavia, Italy.; Department of Brain and Behavioral Sciences, University of Pavia , Pavia, Italy.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Dec; Vol. 21 (18), pp. 2279-2291. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antiparkinson Agents/*therapeutic use
Dopamine Agonists/*therapeutic use
Levodopa/*therapeutic use
Parkinson Disease/*drug therapy
Antiparkinson Agents/administration & dosage ; Antiparkinson Agents/adverse effects ; Clinical Trials as Topic ; Dopamine Agonists/administration & dosage ; Dopamine Agonists/adverse effects ; Drug Administration Schedule ; Drug Evaluation, Preclinical ; Humans ; Levodopa/administration & dosage ; Levodopa/adverse effects ; Motor Activity/drug effects ; Parkinson Disease/metabolism ; Treatment Outcome
Czasopismo naukowe
Tytuł :
How to introduce a rotigotine patch to Parkinson's disease patients taking oral dopamine agonists.
Autorzy :
Yasutaka Y; Department of Pharmaceutical and Health Care Management, Faculty of Pharmaceutical Science, Fukuoka University, Japan; Department of Hospital Pharmacy, Fukuoka University Hospital, Japan.
Fujioka S; Department of Neurology, Faculty of Medicine, Fukuoka University, Japan. Electronic address: .
Mishima T; Department of Neurology, Faculty of Medicine, Fukuoka University, Japan.
Shibaguchi H; Department of Hospital Pharmacy, Fukuoka University Hospital, Japan.
Tsuboi Y; Department of Neurology, Faculty of Medicine, Fukuoka University, Japan.
Kamimura H; Department of Pharmaceutical and Health Care Management, Faculty of Pharmaceutical Science, Fukuoka University, Japan; Department of Hospital Pharmacy, Fukuoka University Hospital, Japan.
Pokaż więcej
Źródło :
Clinical neurology and neurosurgery [Clin Neurol Neurosurg] 2020 Dec; Vol. 199, pp. 106266. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji :
Journal Article
MeSH Terms :
Dopamine Agonists/*administration & dosage
Parkinson Disease/*drug therapy
Parkinson Disease/*psychology
Tetrahydronaphthalenes/*administration & dosage
Thiophenes/*administration & dosage
Administration, Cutaneous ; Administration, Oral ; Aged ; Dopamine Agonists/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Parkinson Disease/diagnosis ; Psychoses, Substance-Induced/diagnosis ; Psychoses, Substance-Induced/etiology ; Retrospective Studies ; Tetrahydronaphthalenes/adverse effects ; Thiophenes/adverse effects
Czasopismo naukowe
Tytuł :
An evaluation of subcutaneous apomorphine for the treatment of Parkinson's disease.
Autorzy :
Müller T; Department of Neurology, St. Joseph Hospital Berlin-Weißensee , Berlin, Germany.
Pokaż więcej
Źródło :
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2020 Oct; Vol. 21 (14), pp. 1659-1665. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antiparkinson Agents/*administration & dosage
Apomorphine/*administration & dosage
Dopamine Agonists/*administration & dosage
Parkinson Disease/*drug therapy
Antiparkinson Agents/adverse effects ; Antiparkinson Agents/therapeutic use ; Apomorphine/adverse effects ; Apomorphine/therapeutic use ; Disease Progression ; Dopamine Agonists/adverse effects ; Dopamine Agonists/therapeutic use ; Humans ; Injection Site Reaction ; Injections, Subcutaneous ; Levodopa/administration & dosage ; Levodopa/adverse effects ; Levodopa/therapeutic use ; Subcutaneous Tissue/drug effects ; Subcutaneous Tissue/immunology
Czasopismo naukowe
Tytuł :
The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists.
Autorzy :
Wu Z; Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Zheng Y; Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Xie W; Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Li Q; Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Zhang Y; Department of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Ren B; Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Cai L; Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Cheng Y; Department of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Tang H; Department of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Su Z; Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. Electronic address: .
Wu ZB; Department of Neurosurgery, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China; Department of Neurosurgery, Center of Pituitary Tumor, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Electronic address: .
Pokaż więcej
Źródło :
Molecular and cellular endocrinology [Mol Cell Endocrinol] 2020 Dec 01; Vol. 518, pp. 111033. Date of Electronic Publication: 2020 Sep 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenoma/*drug therapy
Dopamine Agonists/*therapeutic use
Drug Resistance, Neoplasm/*genetics
Pituitary Neoplasms/*drug therapy
Adenoma/genetics ; Adenoma/pathology ; Animals ; Autophagy-Related Protein 7/physiology ; Cell Line, Tumor ; Dopamine Agonists/pharmacology ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; MicroRNAs/physiology ; Pituitary Neoplasms/genetics ; Pituitary Neoplasms/pathology ; Prolactinoma/drug therapy ; Prolactinoma/genetics ; Prolactinoma/pathology ; RNA, Long Noncoding/physiology ; Rats ; Signal Transduction/genetics ; Signal Transduction/physiology ; Somatotrophs/metabolism ; Somatotrophs/pathology
Czasopismo naukowe
Tytuł :
Ropinirole, a dopamine agonist with high D 3 affinity, reduces proactive inhibition: A double-blind, placebo-controlled study in healthy adults.
Autorzy :
Rawji V; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square, London, UK. Electronic address: .
Rocchi L; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square, London, UK.
Foltynie T; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square, London, UK.
Rothwell JC; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square, London, UK.
Jahanshahi M; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square, London, UK.
Pokaż więcej
Źródło :
Neuropharmacology [Neuropharmacology] 2020 Nov 15; Vol. 179, pp. 108278. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Inhibition, Psychological*
Dopamine Agonists/*administration & dosage
Indoles/*administration & dosage
Reaction Time/*drug effects
Receptors, Dopamine D3/*agonists
Administration, Oral ; Adult ; Dopamine Agonists/metabolism ; Double-Blind Method ; Female ; Humans ; Indoles/metabolism ; Male ; Reaction Time/physiology ; Receptors, Dopamine D3/metabolism ; Young Adult
Czasopismo naukowe
Tytuł :
Dopamine D1 receptor agonist A-68930 ameliorates Aβ 1-42 -induced cognitive impairment and neuroinflammation in mice.
Autorzy :
Cheng ZY; Department of Pharmacology, China Pharmaceutical University, Nanjing, China.
Xia QP; Department of Pharmacology, China Pharmaceutical University, Nanjing, China.
Hu YH; Department of Pharmacology, China Pharmaceutical University, Nanjing, China.
Wang C; Department of Pharmacology, China Pharmaceutical University, Nanjing, China.
He L; Department of Pharmacology, China Pharmaceutical University, Nanjing, China. Electronic address: .
Pokaż więcej
Źródło :
International immunopharmacology [Int Immunopharmacol] 2020 Nov; Vol. 88, pp. 106963. Date of Electronic Publication: 2020 Sep 10.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Inflammatory Agents/*therapeutic use
Chromans/*therapeutic use
Cognitive Dysfunction/*drug therapy
Dopamine Agonists/*therapeutic use
Encephalitis/*drug therapy
Neurodegenerative Diseases/*drug therapy
Amyloid beta-Peptides ; Animals ; Anti-Inflammatory Agents/pharmacology ; Cell Line ; Cerebral Cortex/drug effects ; Cerebral Cortex/immunology ; Cerebral Cortex/pathology ; Chromans/pharmacology ; Cognitive Dysfunction/immunology ; Cognitive Dysfunction/pathology ; Cytokines/immunology ; Dopamine Agonists/pharmacology ; Encephalitis/immunology ; Encephalitis/pathology ; Hippocampus/drug effects ; Hippocampus/immunology ; Hippocampus/pathology ; Male ; Mice, Inbred ICR ; Neurodegenerative Diseases/immunology ; Neurodegenerative Diseases/pathology ; Neurons/drug effects ; Neurons/pathology ; Peptide Fragments
Czasopismo naukowe
Tytuł :
Лечение антипсихотик-индуцированного паркинсонизма у пациентов с шизофренией .
Autorzy :
Е. Э., Вайман
Н. А., Шнайдер
Н. Г., Незнанов
Р. Ф., Насырова
Pokaż więcej
Alternatywny tytuł :
Treatment of antipsychotic-induced parkinsonism in schizophrenic patients.
Źródło :
Neurology, Neuropsychiatry, Psychosomatics. 2021, Vol. 13 Issue 4, p4-11. 8p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies